Synthetic vs Natural ECMs for 3D Cell Culture

Team Dynamic Matrices | 8 November 2025

The extracellular matrix is not scaffolding. It signals. Adhesion sites, growth-factor reservoirs, stiffness, stress relaxation and degradability all instruct cells on how to spread, divide, differentiate and organise. So the choice between a natural and a synthetic matrix is a choice about which of those instructions are present and how much of them you control. Here is how we think about it, with the caveat that we make a synthetic one.

Natural ECMs: high fidelity, low control

Basement membrane extracts (Matrigel, Cultrex, Geltrex), decellularised tissue ECM, and purified proteins such as collagen I and fibrin all present cells with native-like adhesion motifs and structural proteins. That is why they work out of the box for so many cell types.

The cost is control. Composition is undefined or coupled: Hughes et al. (Proteomics, 2010) found more than 1,800 proteins in Matrigel with lot-variable growth factor content. Mechanics are coupled to protein concentration, so you cannot stiffen collagen without also adding more adhesion sites and changing fibre architecture. Animal origin adds translational and ethical issues, and immune-relevant assays inherit whatever endotoxin and cytokine load the extract carries. Aisenbrey and Murphy (Nature Reviews Materials, 2020) summarise the situation well: natural matrices are limited by batch variability and by tunability, not by biology.

Synthetic ECMs: defined, tunable, reproducible

Synthetic matrices build from defined components (PEG, polyacrylamide, DNA-crosslinked polymers, self-assembling peptides) and add adhesion ligands deliberately. What you get:

• Chemically defined composition, so what you report is what the cells saw
• Batch consistency, since the material is manufactured to a specification rather than extracted
• Animal-free sourcing
• Independent mechanical tunability, so stiffness can be varied at fixed ligand density and vice versa

The historic criticism was that synthetic gels are biologically inert and mechanically unrealistic. Both criticisms were fair a decade ago. Adhesive peptides (RGD, GFOGER, IKVAV, laminin-derived motifs), protease-cleavable crosslinks and, most recently, dynamic viscoelastic crosslinking have closed most of the gap. Chaudhuri et al. (Nature, 2020) reviewed why stress relaxation matters as much as stiffness, and DNA-crosslinked systems now reproduce tissue-like relaxation while remaining fully defined (Peng et al., Nature Nanotechnology, 2023).

The remaining honest limitation: you have to supply the biology. If a lineage needs a specific growth-factor-binding proteoglycan or an unusual laminin isoform, you need to know that and add it.

Semi-synthetic scaffolds

Synthetic backbones carrying natural components (PEG-fibrinogen, HA-based gels, gelatin methacrylate). They aim to balance bioactivity and control and often succeed for specific applications. They also inherit complexity from both parents: a variable natural component inside an otherwise defined gel. Useful when you have a clear reason; rarely the best default.

Where each wins

A decision framework

Choose a natural matrix when the question is exploratory, the cell type is new to you, matching a published protocol matters, and some variability is tolerable.

Choose a synthetic matrix when reproducibility, control or translatability is essential: mechanobiology, compound screening, longitudinal studies, multi-site work, anything headed toward the clinic.

Increasingly the decision is made for you: reviewers ask why an animal extract was used, NAM guidance from FDA and EMA favours defined systems, and several pharma partners we work with now require animal-free matrices in new assays regardless of scientific preference.